← Intelligence Vault
methodologyExpert Opinion1 min read
Fitzpatrick skin type and treatment response: implications for personalized dermatology
Authors · Ware OR, Dawson JE, Shinohara MM et al.
Journal · Cutis · June 2020
What this means for you
The plain-language read
Fitzpatrick skin types I–VI predict UV response, pigmentation risk, and treatment tolerance. Types IV–VI carry elevated risk of post-inflammatory hyperpigmentation (PIH) from aggressive exfoliation, laser, and inflammatory dermatoses. Personalized protocols adjust active concentrations, downtime, and adjunctive depigmenting therapy by skin type.
Key findings
- Fitzpatrick IV–VI carry elevated PIH risk universally
- Personalization framework: reduce, prime, prophylax
- Azelaic acid and tranexamic acid are workhorses in skin of color
- Hydroquinone use requires special caution (ochronosis risk)
Practical note
For Fitzpatrick IV–VI patients: prime 4 weeks with niacinamide 4% before introducing exfoliating actives. Use mineral SPF daily. Have azelaic acid 15% on standby for PIH prophylaxis around any inflammatory event.
Translate to action
What this means for your routine
azelaic acidAM/PM routine
If you're targeting hyperpigmentation, this research supports adding azelaic acid to your AM/PM routine.
tranexamic acidAM/PM routine
If you're targeting hyperpigmentation, this research supports adding tranexamic acid to your AM/PM routine.
Translated from this study's findings, not a personal prescription. Pair with your existing protocol and your practitioner's guidance.
Technical Summary, For Professional Reference
Clinical context
Fitzpatrick IV–VI carry elevated PIH risk from any inflammation. Personalization framework: reduced active starting concentrations, longer titration windows, ahead-of-time priming with niacinamide or azelaic acid, prophylactic PIH management protocols around in-office procedures. Specific risks: laser-induced PIH, AHA/BHA-induced PIH, comedone-extraction PIH.
Ingredients discussed
Full abstract→
Fitzpatrick skin types I–VI predict UV response, pigmentation risk, and treatment tolerance. Types IV–VI carry elevated risk of post-inflammatory hyperpigmentation (PIH) from aggressive exfoliation, laser, and inflammatory dermatoses. Personalized protocols adjust active concentrations, downtime, and adjunctive depigmenting therapy by skin type.
Original source →